Human Pharmaceutical Portfolio

Du kinib 250 mg Capsule

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthLapatinib 250 mg
ManufacturerSayre Therapeutics Pvt Ltd
CategoryAnti-Cancer
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.